Injected arthritis drug reduces risk of death from Covid-19 by 4%, study finds
The NHS will start using an arthritis drug to treat hospitalised Covid patients after a breakthrough study found it cuts the risk of dying. Tocilizumab can reduce swelling inside the organs and, when combined with steroid dexamethasone slashes the odds of death by up to 50 per cent. It can also cut the time spent in … Read more